Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BrdU Antikörper (FITC)

BrdU IF (p), IF (cc) Wirt: Kaninchen Polyclonal FITC
Produktnummer ABIN669253
  • Target Alle BrdU Antikörper anzeigen
    BrdU (Bromodeoxyuridine (BrdU))
    Reaktivität
    Bitte anfragen
    Wirt
    • 41
    • 21
    • 4
    • 2
    Kaninchen
    Klonalität
    • 49
    • 19
    Polyklonal
    Konjugat
    • 29
    • 6
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Dieser BrdU Antikörper ist konjugiert mit FITC
    Applikation
    • 25
    • 25
    • 21
    • 19
    • 17
    • 16
    • 13
    • 11
    • 10
    • 7
    • 7
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))
    Kreuzreaktivität
    Human, Ratte
    Kreuzreaktivität (Details)
    BrdU
    Aufreinigung
    Purified by Protein A.
    Immunogen
    BrdU conjugated to KLH
    Isotyp
    IgG
    Top Product
    Discover our top product BrdU Primärantikörper
  • Applikationshinweise
    IF(IHC-P) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Target
    BrdU (Bromodeoxyuridine (BrdU))
    Andere Bezeichnung
    BrdU (BrdU Produkte)
    Substanzklasse
    Chemical
    Hintergrund

    Synonyms: Bromodeoxyuridine, Bromodeoxyuridine, 5-Bromo-2-deoxyuridine, 5-BrdU, proliferation Marker.

    Background: The immunocytochemical detection of bromodeoxyuridine (BrdU) incorporated into DNA is a powerful tool to study the cytokinetics of normal and neoplastic cells. In vitro or in vivo labeling of tumor cells with the thymidine analogue BrdU and the subsequent detection of incorporated BrdU with specific anti-BrdU monoclonal is an accurate and comprehensive method to quantitate the degree of DNA-synthesis.BrdU is incorporated into the newly synthezised DNA of S-phase cells may provide an estimate for the fraction of cells in S-phase. Also dynamic proliferative information such as the S-phase transit rate and the potential doubling time can be obtained, by means of bivariate BrdU/DNA flow cytometric analysis

Sie sind hier:
Kundenservice